# To Assess the Role of Fecal Microbiota Transplant in Acute Liver Failure

> **NCT03363022** · NA · WITHDRAWN · sponsor: **Institute of Liver and Biliary Sciences, India**

## Conditions studied

- Acute Liver Failure

## Interventions

- **DRUG:** Standard Medical Treatment
- **OTHER:** Fecal Microbiota Transplant
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03363022
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-02-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of Funds
- **Last updated:** 2019-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03363022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03363022, "To Assess the Role of Fecal Microbiota Transplant in Acute Liver Failure". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT03363022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*